Tizanidine hydrochloride and Concerta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tizanidine hydrochloride (tizanidine hydrochloride) and Concerta (methylphenidate hydrochloride). Common drug interactions include sleep-related eating disorder among females and bone pain among males.

The phase IV clinical study analyzes what interactions people have when they take Tizanidine hydrochloride and Concerta. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Tizanidine hydrochloride?

Tizanidine hydrochloride has active ingredients of tizanidine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 7,453 Tizanidine hydrochloride users. Check the latest studies of Tizanidine hydrochloride.

What is Concerta?

Concerta has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 25,040 Concerta users. Check the latest studies of Concerta.



On Jul, 31, 2026

26 people who take Tizanidine hydrochloride and Concerta together, and have interactions are studied.

Tizanidine hydrochloride and Concerta drug interactions.

What are the common drug interactions of Tizanidine Hydrochloride and Concerta, by gender? *:

female:

  1. Sleep-related eating disorder (abnormal eating patterns during the night)
  2. Somnambulism (sleep walking)
  3. Weight decreased
  4. Fall
  5. Abnormal sleep-related event
  6. Head injury
  7. Urinary tract infection
  8. Fatigue (feeling of tiredness)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

male:

  1. Bone pain
  2. Fatigue (feeling of tiredness)
  3. Injection site pain
  4. Injection site reaction
  5. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  6. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Pyrexia (fever)

What are the common drug interactions of Tizanidine Hydrochloride and Concerta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Intervertebral disc degeneration (spinal disc degeneration)

40-49:

  1. Concussion (short loss of normal brain function in response to a head injury)
  2. Drug ineffective
  3. Dry mouth
  4. Headache (pain in head)
  5. Hypertension (high blood pressure)
  6. Migraine (headache)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Visual impairment

50-59:

  1. Suicide attempt
  2. Anxiety
  3. Fall
  4. Panic attack
  5. Syncope (loss of consciousness with an inability to maintain postural tone)

60+:

  1. Fatigue (feeling of tiredness)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Respiratory tract congestion (blockage on respiratory system)
  4. Skin disorder (skin disease)
  5. Skin fragility (trauma-induced blisters and erosions of skin)
  6. Spinal fusion surgery
  7. Urinary tract infection
  8. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  9. Arthralgia (joint pain)
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 42.31%
  2. Asthma: 9 people, 34.62%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 26.92%
  4. Drowsiness: 5 people, 19.23%
  5. Immunodeficiency Common Variable: 3 people, 11.54%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 11.54%
  7. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 7.69%
  8. Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tizanidine hydrochloride and Concerta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tizanidine hydrochloride and Concerta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tizanidine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Concerta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tizanidine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Concerta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on tizanidine hydrochloride and methylphenidate hydrochloride (the active ingredients of Tizanidine hydrochloride and Concerta, respectively), and Tizanidine hydrochloride and Concerta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: